Filtros de búsqueda

Lista de obras de Nicolas Penel

"Classical 3 + 3 design" versus "accelerated titration designs": analysis of 270 phase 1 trials investigating anti-cancer agents.

artículo científico publicado en 2009

"Impossible" patients in oncology: Two unusual cases

artículo científico publicado en 2018

A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome.

artículo científico publicado en 2017

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

artículo científico publicado en 2013

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

artículo científico publicado en 2020

A noninterventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma.

artículo científico publicado en 2017

A paradigm shift in tumour response evaluation of targeted therapy: the assessment of novel drugs in exploratory clinical trials

artículo científico

A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors.

artículo científico publicado en 2012

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

artículo científico publicado en 2015

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy.

artículo científico publicado en 2017

A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosa.

artículo científico publicado en 2006

A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.

artículo científico publicado en 2009

ASCO 2016: Confirmation of respective roles of docetaxel and cabazitaxel in prostate cancer patients

artículo científico publicado en 2016

Activity endpoints reported in soft tissue sarcoma phase II trials: quality of reported endpoints and correlation with overall survival.

artículo científico publicado en 2013

Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis

scientific article published on 19 November 2007

Adjuvant radiation therapy in metastatic lymph nodes from melanoma

artículo científico publicado en 2011

Adult desmoid tumors: biology, management and ongoing trials.

artículo científico publicado en 2017

Advanced Abrikossoff tumour: a metastatic or a multifocal malignancy?

artículo científico publicado en 2011

Advanced chondrosarcomas: role of chemotherapy and survival.

artículo científico publicado en 2013

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).

artículo científico publicado en 2017

Angiosarcoma: state of the art and perspectives.

artículo científico publicado en 2010

Anti-PLD1 and anti-PD1 in advanced urothelial cancers: promises from early phase trials

artículo científico publicado en 2016

Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study

artículo científico publicado en 2015

Are there criteria for the diagnosis of paraneoplastic fever?

artículo científico publicado en 2000

Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma

artículo científico publicado en 2016

Autoimmune hypophysitis associated with new anti-cancer immunotherapies

artículo científico publicado en 2018

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.

artículo científico publicado en 2017

Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)

artículo científico publicado en 2018

Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis.

artículo científico publicado en 2011

Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis

artículo científico publicado en 2007

Cancer-associated hypercalcemia: validation of a bedside prognostic score

scientific article published on 17 March 2009

Carcinoma of unknown primary site: From necropsy to epigenetic analysis

artículo científico publicado en 2016

Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.

artículo científico publicado en 2004

Chondrosarcoma of the femur in Mazabraud's syndrome: A first case study

artículo científico publicado en 2015

Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapy

scientific article published on 07 May 2010

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO).

artículo científico publicado en 2016

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.

artículo científico publicado en 2012

Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.

artículo científico publicado en 2011

Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis.

artículo científico publicado en 2014

Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective stud

artículo científico publicado en 2016

Crossed views of burden and emotional distress of cancer patients and family caregivers during palliative care.

artículo científico publicado en 2015

Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?

artículo científico publicado en 2012

Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals

artículo científico publicado en 2020

Determining the length of posttherapeutic follow-up for cancer patients using competing risks modeling

artículo científico publicado en 2013

Development and validation of a bedside score to predict early death in cancer of unknown primary patients

artículo científico publicado en 2009

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics

article

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)

scientific article published on 12 February 2020

Development of a score that predicts survival among patients with bone metastasis revealing solid tumor

artículo científico publicado en 2008

Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma? ⬇️

artículo científico publicado el 1 de diciembre de 2012

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis

artículo científico publicado en 2006

Docetaxel and prostate cancer: Early but not too early

artículo científico publicado en 2015

Dose-Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study

article

Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials

artículo científico publicado en 2011

Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma.

artículo científico publicado en 2010

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol

artículo científico publicado en 2019

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

artículo científico publicado en 2012

Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group.

artículo científico publicado en 2014

Efficacy and safety of 153Sm-EDTMP as treatment of painful bone metastasis: a large single-center study.

artículo científico publicado en 2017

Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review ⬇️

artículo científico publicado el 13 de agosto de 2013

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group

artículo científico publicado en 2015

Erratum

Factors determining length of the postoperative hospital stay after major head and neck cancer surgery

artículo científico publicado en 2007

Factors favouring palliative treatment multidisciplinary decisions for newly diagnosed visceral and soft tissue sarcomas.

artículo científico publicado en 2008

Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients

artículo científico publicado en 2009

Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502)

scientific article published on 20 January 2010

First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control

scientific article published on 20 January 2016

First-line management of metastatic castrate-resistant prostate cancer patients: Audit of real-life practices

artículo científico publicado en 2017

Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases

artículo científico publicado en 2008

Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials.

artículo científico publicado en 2015

Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics

artículo científico publicado en 2013

Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors

artículo científico publicado en 2018

Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio.

artículo científico publicado en 2015

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

artículo científico publicado en 2012

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

artículo científico publicado en 2014

Head and neck cancer surgery in the elderly--does age influence the postoperative course?

scientific article published on 29 December 2009

Head and neck soft tissue sarcomas of adult: prognostic value of surgery in multimodal therapeutic approach.

artículo científico publicado en 2004

Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis

scientific article published on 31 August 2019

How to emerge from the conservatism in clinical research methodology?

artículo científico publicado en 2017

How to report toxicity associated with targeted therapies?

artículo científico publicado en 2016

Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship?

artículo científico publicado en 2011

Imatinib as a possible cause of severe rhabdomyolysis

artículo científico publicado en 2008

Imatinib in gastrointestinal stromal tumor: does treatment duration matter?

artículo científico publicado en 2009

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial

artículo científico publicado en 2018

Improved survival using specialized multidisciplinary board in sarcoma patients

artículo científico publicado en 2017

Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study

artículo científico publicado en 2015

Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients.

artículo científico publicado en 2009

Inappropriate dose of multitargeted tyrosine kinase inhibitors: the original sin.

artículo científico publicado en 2016

Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients

artículo científico publicado en 2016

Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary.

scientific article published on 30 March 2010

Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: illustration over a 20-year period

artículo científico publicado en 2012

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

artículo científico publicado en 2015

Is adjuvant chemotherapy useful in lobular breast cancer patients?

artículo científico publicado en 2011

Life-expectancy of patients enrolled in phase 1 clinical trials: a systematic review of published prognostic models.

artículo científico

Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)

artículo científico publicado en 2012

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy

scientific article published on 02 June 2018

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

artículo científico publicado en 2013

Long-term recurrence of soft tissue sarcomas: Prognostic factors and implications for prolonged follow-up

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial

artículo científico publicado en 2013

L’année 2015 à travers le regard du comité de rédaction du Bulletin du cancer

scholarly article by Nicolas Magné et al published January 2016 in Bulletin du Cancer

Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).

artículo científico publicado en 2016

Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literature.

artículo científico publicado en 2012

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

artículo científico publicado en 2016

Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.

artículo científico publicado en 2014

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

artículo científico publicado en 2010

Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review

artículo científico publicado en 2017

Metabolic disorders associated with the use of targeted cancer therapies.

artículo científico publicado en 2015

Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome

artículo científico publicado en 2011

Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.

artículo científico publicado en 2015

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

artículo científico publicado en 2008

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial

artículo científico publicado en 2018

Nomogram to predict treatment outcome of fluoropyrimidine/platinum-based chemotherapy in metastatic esophageal squamous cell carcinoma.

artículo científico publicado en 2013

Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.

artículo científico publicado en 2018

O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.

artículo científico publicado en 2008

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial

artículo científico publicado en 2015

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

artículo científico publicado en 2018

Oral metronomic cyclophosphamide in elderly with metastatic melanoma

artículo científico publicado en 2009

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

artículo científico publicado en 2018

Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database

artículo científico publicado en 2014

PRognostic factor of Early Death In phase II Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model).

artículo científico publicado en 2016

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

artículo científico publicado en 2015

Pain burden in desmoid tumor patients: a survey of the French Advocacy Group SOS Desmoid.

artículo científico publicado en 2015

Participation in randomised clinical trials is linked to emotion regulation strategies.

artículo científico publicado en 2010

Patient selection for oncology phase I trials: a multi-institutional study of prognostic factors

artículo científico publicado en 2012

Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

artículo científico publicado en 2019

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (

article

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma

artículo científico publicado en 2020

Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer

artículo científico publicado en 2013

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

artículo científico publicado en 2008

Phase II trials in patients with carcinoma of unknown primary: a pooled data analysis

artículo científico publicado en 2009

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

artículo científico publicado en 2009

Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study

scientific article published on December 2010

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin ⬇️

artículo científico publicado el 21 de agosto de 2012

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

artículo científico publicado en 2017

Predictive value of clinical judgment of tumour progression in phase II trials

artículo científico publicado en 2012

Predictors for establishing recommended phase 2 doses: analysis of 320 dose-seeking oncology phase 1 trials

artículo científico publicado en 2010

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

artículo científico publicado en 2017

Previous chemotherapy as a predictor of wound infections in nonmajor head and neck surgery: Results of a prospective study

artículo científico publicado en 2004

Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.

artículo científico publicado en 2013

Primary mucosal melanoma of head and neck: prognostic value of clear margins.

artículo científico publicado en 2006

Primitive neuroectodermal tumour of the duodenum with unexpected lymph node involvement

artículo científico publicado en 2008

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

scientific article published on 11 October 2018

Prognostic factors among cancer patients with good performance status screened for phase I trials

scientific article published on 22 September 2007

Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks setting

artículo científico publicado en 2014

Prognostic factors for adult sarcomas of head and neck

artículo científico publicado en 2008

Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study.

artículo científico publicado en 2004

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study

artículo científico publicado en 2019

Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR.

artículo científico publicado en 2018

Proposal for size justification of expanded cohort at phase-2-recommended dose.

artículo científico publicado en 2010

Prostate cancer and DNA repair genes

artículo científico publicado en 2017

Prostate cancer related haemophagocytic syndrome: successful treatment with chemotherapy

scientific article published on 22 September 2011

Psychosocial factors involved in delayed consultation by patients with head and neck cancer.

artículo científico publicado en 2005

Pulmonary blastoma in adult: dramatic but transient response to doxorubicin plus ifosfamide

scientific article published on 29 July 2010

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib

scientific article published on 01 April 2020

REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis

artículo científico publicado en 2017

Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients.

artículo científico publicado en 2011

Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)

artículo científico publicado en 2018

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas

artículo científico

Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma G

article

Reappraisal of eligibility criteria in cancer clinical trials

artículo científico publicado en 2018

Regorafenib use as a possible cause of intestinal perforation

artículo científico publicado en 2013

Reply to B. Biswas and D. Dabkara.

artículo científico publicado en 2015

Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patients

artículo científico publicado en 2016

Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study

scientific article published on 19 July 2019

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy

artículo científico publicado en 2013

Risk factors for early catheter-related infections in cancer patients

artículo científico publicado en 2007

Role of the investigator in phase 1 trials of anticancer drugs ⬇️

artículo científico publicado el 13 de noviembre de 2012

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

artículo científico publicado en 2016

Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years

scientific article published on 15 April 2019

Selection of ultimately ill cancer patients able to fulfill a questionnaire: Identification of inherent biases.

artículo científico publicado en 2015

Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.

artículo científico publicado en 2012

Silent hereditary hematochromatosis as a susceptibility factor of doxorubicin-induced acute cardiac failure

artículo científico publicado en 2010

Soft tissue sarcoma associated with chronic lymphocytic leukemia: about 5 cases

artículo científico publicado en 2005

Soft tissue sarcomas or intramuscular haematomas?

artículo científico publicado en 2009

Soft tissue sarcomas: Questions about reported clinical benefit

artículo científico publicado en 2015

Solitary fibrous tumors and so-called hemangiopericytoma.

artículo científico publicado en 2012

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

artículo científico publicado en 2012

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study.

artículo científico publicado en 2016

Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).

artículo científico publicado en 2013

Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO).

artículo científico publicado en 2013

Splicing variant of androgen receptors (AR-V7): New paradigms

artículo científico publicado en 2016

Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group

artículo científico publicado en 2013

Statistical controversies in clinical research: should schedules of tumor size assessments be changed?

artículo científico publicado en 2016

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

artículo científico publicado en 2015

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

artículo científico publicado en 2017

Switch in use of midazolam for cancer patients during the COVID-19 pandemic

artículo científico publicado en 2020

Targeting angiogenesis in advanced soft tissue sarcoma: tivozanib-hype or me-too?

artículo científico publicado en 2017

Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years.

artículo científico publicado en 2010

The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors

artículo científico publicado en 2014

The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patients

scientific article published on 01 July 2018

The off-label use of targeted therapies in sarcomas: the OUTC'S program

artículo científico publicado en 2014

The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value

artículo científico publicado en 2015

Time interval between surgery and start of adjuvant radiotherapy in patients with soft tissue sarcoma: A retrospective analysis of 1131 cases from the French Sarcoma Group

artículo científico publicado en 2016

Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.

artículo científico publicado en 2011

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

artículo científico publicado en 2015

Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group

artículo científico publicado en 2015

Trabectedin is an effective second-line treatment in soft tissue sarcoma patients

scientific article published on 24 November 2015

Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors ⬇️

artículo científico publicado el 23 de noviembre de 2012

Treatment of adult patients with metastatic sarcoma: current shift in concepts

artículo científico publicado en 2010

Tumor calcification: a new response pattern of myxoid liposarcoma to trabectedin.

artículo científico publicado en 2014

Tumor lysis syndrome with symptomatic hyperuricemia after a first chemotherapeutic treatment of undifferentiated carcinoma of the cavum

artículo científico publicado en 2002

Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders

artículo científico publicado en 2019

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial

artículo científico publicado en 2018

Usefulness of social and educational approach in adolescents and young adults with cancer: The Lille team's experience

artículo científico publicado en 2016

Vinorelbine in breast cancer

artículo científico publicado en 2008

What does a modified-Fibonacci dose-escalation actually correspond to?

artículo científico publicado en 2012

What is an active regimen in carcinoma of unknown primary sites? Analysis of correlation between activity endpoints reported in phase II trials. Correlation of activity endpoints in phase II trials.

artículo científico

When cancerophobia and denial lead to death

artículo científico publicado en 2009

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

artículo científico publicado en 2016

[2017 ASCO: Complete androgen blockade strikes back].

artículo científico publicado en 2017

[Adjuvant chemotherapy for upper tract urothelial cancer: Level of evidence IA]

scientific article published on 17 September 2018

[An index of understanding randomised clinical trials in oncology]

artículo científico publicado en 2009

[Association soft tissue sarcoma and familial adenomatous polyposis: a case-report].

artículo científico publicado en 2005

[Before seasonal influenza, vaccination of cancer patients and healthcare givers]

scientific article published on 30 January 2019

[Cancer screening words]

scientific article published on 16 April 2019

[Clinical equipoise and randomised clinical trials in oncology]

artículo científico publicado en 2009

[Definitions of target volumes in soft tissue sarcomas of the extremities]

scientific article published on 01 October 2001

[Dermatofibrosarcoma: Management]

artículo científico publicado en 2018

[Evolution of the regulatory framework in clinical research]

scientific article published on 15 March 2019

[French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak]

scientific article published on 01 April 2020

[Merkel cell carcinoma: current diagnosis and treatment]

scientific article published on 01 September 2008

[Methodological approaches of clinical studies with targeted therapies]

artículo científico publicado en 2008

[Phase 1 of clinical trial: The issue of dose-escalating]

artículo científico publicado en 2016

[Phases 0, 1 and 2 oncology clinical trials: current questions]

scientific article published on 01 January 2010

[Primary leiomyosarcoma of pulmonary artery: a rare tumor mis-diagnosed as pulmonary embolism]

scientific article published on 01 January 2003

[Primary soft tissue sarcoma of the chest in adults: a retrospective study of 40 cases]

artículo científico publicado en 2003

[Prognosis of post-irradiation soft-tissue sarcoma: case-control study]

artículo científico publicado en 2004

[Prognostic and predictive factors of soft tissue sarcoma: a daily use of translational research]

artículo científico publicado en 2009

[Renal colic due to kidney metastase from larynx cancer]

artículo científico publicado en 2003

[Requirement of DPD deficiency screening before prescription of fluoropyrimidines]

artículo científico publicado en 2018

[Soft sarcoma tissue of extremities: medical imagery in post-therapeutic follow-up]

artículo científico publicado en 2005

[Soft tissue sarcoma: role of imaging for initial diagnosis and treatment]

artículo científico publicado en 2005

[Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3].

artículo científico publicado en 2017

[Ultra-late metastasis of ocular melanoma: about two cases]

scientific article published on 01 February 2004

[What role for the direct oral anticoagulants in oncology?]

artículo científico publicado en 2018

[Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board]

artículo científico publicado en 2016

[β-catenin and desmoid tumors: The ideal biomarker?]

scientific article published on 20 December 2016

irRECIST and iRECIST: the devil is in the details

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda